Aipo Diao

1.9k total citations
61 papers, 1.5k citations indexed

About

Aipo Diao is a scholar working on Molecular Biology, Epidemiology and Cell Biology. According to data from OpenAlex, Aipo Diao has authored 61 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 8 papers in Epidemiology and 8 papers in Cell Biology. Recurrent topics in Aipo Diao's work include Ubiquitin and proteasome pathways (9 papers), Advanced biosensing and bioanalysis techniques (8 papers) and Autophagy in Disease and Therapy (8 papers). Aipo Diao is often cited by papers focused on Ubiquitin and proteasome pathways (9 papers), Advanced biosensing and bioanalysis techniques (8 papers) and Autophagy in Disease and Therapy (8 papers). Aipo Diao collaborates with scholars based in China, United Kingdom and Japan. Aipo Diao's co-authors include Martin Lowe, Yuyin Li, Long Ma, John M. Lucocq, Darryl Pappin, Dinah Rahman, Shamshad Cockcroft, Alison Skippen, Laura S. Frost and Zhenxing Liu and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Cell Biology and The EMBO Journal.

In The Last Decade

Aipo Diao

57 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aipo Diao China 23 911 482 165 161 138 61 1.5k
Adel F.M. Ibrahim United Kingdom 20 1.5k 1.6× 177 0.4× 122 0.7× 180 1.1× 66 0.5× 33 1.8k
Stephanie E. Brown United Kingdom 20 1.7k 1.9× 318 0.7× 68 0.4× 239 1.5× 44 0.3× 27 2.3k
Serena Rinaldo Italy 26 1.1k 1.2× 222 0.5× 87 0.5× 165 1.0× 48 0.3× 77 1.8k
Alina D. Zamfir Romania 32 1.9k 2.0× 797 1.7× 109 0.7× 275 1.7× 404 2.9× 127 2.8k
Yuzuru Kubohara Japan 26 921 1.0× 658 1.4× 55 0.3× 84 0.5× 298 2.2× 89 1.8k
Aleš Vančura United States 26 1.8k 2.0× 319 0.7× 197 1.2× 132 0.8× 98 0.7× 74 2.3k
Hiroyasu Tsutsuki Japan 22 430 0.5× 105 0.2× 58 0.4× 92 0.6× 70 0.5× 62 994
Binghui Li China 23 1.2k 1.4× 114 0.2× 49 0.3× 67 0.4× 74 0.5× 54 1.8k
Jean‐Michel Gaullier Norway 13 1.0k 1.1× 997 2.1× 63 0.4× 427 2.7× 54 0.4× 15 2.0k

Countries citing papers authored by Aipo Diao

Since Specialization
Citations

This map shows the geographic impact of Aipo Diao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aipo Diao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aipo Diao more than expected).

Fields of papers citing papers by Aipo Diao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aipo Diao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aipo Diao. The network helps show where Aipo Diao may publish in the future.

Co-authorship network of co-authors of Aipo Diao

This figure shows the co-authorship network connecting the top 25 collaborators of Aipo Diao. A scholar is included among the top collaborators of Aipo Diao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aipo Diao. Aipo Diao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Zhenxing, Xiaoting Wu, Jiamiao Liu, et al.. (2025). Escin alleviates DNCB-induced atopic dermatitis-like symptoms by promoting autophagy activation and tight junction barrier restoration. The International Journal of Biochemistry & Cell Biology. 189. 106865–106865.
2.
Lin, Jieru E., Lu Li, Yuyin Li, et al.. (2024). The novel TFEB agonist desloratadine ameliorates hepatic steatosis by activating the autophagy-lysosome pathway. Frontiers in Pharmacology. 15. 1449178–1449178.
4.
Sun, Shengnan, Aipo Diao, & Zhen‐Chuan Fan. (2024). Green algae-produced multimer cathelicidin-RC1 disrupts membrane integrity for inhibiting bacterial growth. Process Biochemistry. 146. 1–12.
5.
Sun, Shengnan, et al.. (2023). Chlamydomonas reinhardtii-derived triple BmKbpp distorts membrane integrity for inhibiting bacterial growth. Process Biochemistry. 137. 10–19. 5 indexed citations
6.
Yang, Yang, Lu Li, Yuyin Li, et al.. (2022). The novel prolyl hydroxylase-2 inhibitor caffeic acid upregulates hypoxia inducible factor and protects against hypoxia. European Journal of Pharmacology. 934. 175307–175307. 3 indexed citations
7.
Zhao, Tian, Yujie Liu, Wei Zhang, et al.. (2020). Esomeprazole inhibits the lysosomal cysteine protease legumain to prevent cancer metastasis. Investigational New Drugs. 39(2). 337–347. 11 indexed citations
8.
Zhao, Qing, Jie Pang, Yi Jiang, et al.. (2020). Production of a novel bispecific protein ULBP1×CD19-scFv targeting the NKG2D receptor and CD19 to promote the activation of NK cells. Protein Expression and Purification. 178. 105783–105783. 1 indexed citations
9.
Ma, Long, Nana Sun, Yuanyuan Meng, et al.. (2018). Harnessing the affinity of magnetic nanoparticles toward dye-labeled DNA and developing it as an universal aptasensor revealed by lipopolysaccharide detection. Analytica Chimica Acta. 1036. 107–114. 25 indexed citations
10.
Zhao, Tian, Zhipeng Li, Ali Wang, et al.. (2018). Functional recombinant human Legumain protein expression in Pichia pastoris to enable screening for Legumain small molecule inhibitors. Protein Expression and Purification. 150. 12–16. 8 indexed citations
11.
Liu, Zhenxing, Xin Huo, Shuang Zhao, et al.. (2017). Low density lipoprotein receptor class A domain containing 4 (LDLRAD4) promotes tumorigenesis of hepatic cancer cells. Experimental Cell Research. 360(2). 189–198. 15 indexed citations
12.
Yang, Meng, Dan Lv, Lei Jing, et al.. (2016). TMEPAI increases lysosome stability and promotes autophagy. The International Journal of Biochemistry & Cell Biology. 76. 98–106. 17 indexed citations
13.
Li, Yuyin, Jianjun Wang, Yajuan Feng, et al.. (2016). Lysosome Inhibitors Enhance the Chemotherapeutic Activity of Doxorubicin in HepG2 Cells. Chemotherapy. 62(2). 85–93. 14 indexed citations
15.
Ma, Long & Aipo Diao. (2015). Marizomib, A Potent Second Generation Proteasome Inhibitor from Natural Origin. Anti-Cancer Agents in Medicinal Chemistry. 15(3). 298–306. 34 indexed citations
16.
Li, Qingyan, et al.. (2015). Construction of a novel phenol synthetic pathway in Escherichia coli through 4-hydroxybenzoate decarboxylation. Applied Microbiology and Biotechnology. 99(12). 5163–5173. 32 indexed citations
17.
Diao, Aipo. (2012). Expression and purification of PMEPA1 protein and its antibody preparation. Journal of Shandong University. 1 indexed citations
18.
Ghanekar, Yashoda, et al.. (2008). ZFPL1, a novel ring finger protein required for cis‐Golgi integrity and efficient ER‐to‐Golgi transport. The EMBO Journal. 27(7). 934–947. 29 indexed citations
19.
Chen, Jiong, et al.. (1999). Molecular analysis of barley yellow mosaic virus isolates from China. Virus Research. 64(1). 13–21. 22 indexed citations
20.
Diao, Aipo, Jianping Chen, J. F. Antoniw, et al.. (1999). Sequences of European Wheat Mosaic Virus and Oat Golden Stripe Virus and Genome Analysis of the Genus Furovirus. Virology. 261(2). 331–339. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026